RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Jounce Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Jounce Therapeutics Inc is JNCE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Jounce Therapeutics Inc Stock?
Jounce Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Jounce Therapeutics Inc Stock?
Jounce Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Jounce Therapeutics Inc Stock.

What's the current price of Jounce Therapeutics Inc Stock?
As of the end of day on the 2023-08-02, the price of an Jounce Therapeutics Inc (JNCE) share was $1.88.

What is the 52-week high and low for Jounce Therapeutics Inc Stock?
The 52-week high for Jounce Therapeutics Inc Stock is $5.37 and the 52-week low is $0.577.

What is the market capitalization of Jounce Therapeutics Inc Stock?
As of the 2023-08-02, the market capitalization of Jounce Therapeutics Inc is 98.955M.
Click to get the best stock tips daily for free!

About Jounce Therapeutics Inc

Jounce Therapeutics Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like recepto... JNCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT